A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds

Risk Analysis

Volumn 16, Issue 2, 1996, Pages 147-160

  Roy, A ^a   Weisel, C P ^a   Lioy, P J ^a   Georgopoulos, P G ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Chloroform; dermal; diffusion; PBPK; skin absorption; volatile organic compounds

Indexed keywords

ABSORPTION; CHLORINE COMPOUNDS; DIFFERENTIAL EQUATIONS; DIFFUSION; PARTIAL DIFFERENTIAL EQUATIONS; RESPIRATORY MECHANICS; SKIN; VOLATILE ORGANIC COMPOUNDS;

CHLOROFORM; DERMAL ABSORPTION; DERMAL DOSE; DERMAL MASS FLUX; DISTRIBUTED PARAMETER PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL; FICKIAN DIFFUSION;

MATHEMATICAL MODELS;

CHLOROFORM; VOLATILE ORGANIC COMPOUND;

ARTICLE; DOSE RESPONSE; DRUG DIFFUSION; ENVIRONMENTAL EXPOSURE; PREDICTION; RISK ASSESSMENT; SKIN PENETRATION; VOLATILIZATION;

EID: 0030130947     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1539-6924.1995.tb00773.x     Document Type: Article

References (30)

1. H. S. Brown, D. R. Bishop, and C. A. Rowan, "The Role of Skin Adsorption as a Route of Exposure for Volatile Organic Compounds (VOCs) in Drinking Water," American Journal of Public Health 74, 479-484 (1984).
2. W. Daniell, A. Stebbins, D. Kalman, J. F. O'Donnell, and S. W. Horstman, "The Contributions to Solvent Uptake by Skin, and Inhalation Exposure." American Industrial Hygiene Association Journal 53, 124-129 (1992).
3. W. K. Jo, C. P Weisel, and P. J. Lioy, "Routes of Chloroform Exposure and Body Burden from Showering with Chlorinated Tap Water," Risk Analysis 10, 575-580 (1990).
4. D. R. Mattie, J. H Grabau, and J. N. McDougal, "Significance of the Dermal Route of Exposure to Risk Assessment," Risk Analysis 14(3), 277-284 (1994).
5. K. T. Bogen, "Models based on steady-state in-vitro dermal permeability underestimate short-term in-vivo exposures to organic chemicals," Journal of Exposure Analysis and Environmental Epidemiology 4(4), 457-475 (1994)
6. T. E. McKone, "Linking a PBPK Model for Chloroform with Measured breath Concentrations in Showers: Implications for Dermal Exposure Models," Journal of Exposure Analysis and Environmental Epidemiology 3(3), 339-365 (1993).
7. U.S. EPA, "Dermal Exposure Assessment: Principles and Applications (EPA/600/8-91/011B)," US Environmental Protection Agency, Office of Research and Development, Washington, D.C., Interim Report (January 1992).
8. R. J. Scheuplein and I. H Blank, "Permeability of the Skin," Physiology Review 51, 702-747 (1971).
9. R. L. Cleek and A. L. Bunge, "A New Method of Estimating Dermal Absorption Form Chemical Exposure. 1. General Approach," Pharmaceutical Research 10(4), 497-506 (1993).
10. P. V Raykar, M. C. Fung, and B. D. Anderson, "The Role of Protein and Lipid Domains in the Uptake of Solutes by Human Stratum Corneum," Pharmaceutical Research 5(3), 140-150 (1988).
11. J. Hadgraft, "The Epidermal Reservoir: A Theoretical Approach," International Journal of Pharmaceutics 2, 265-274 (1979).
12. B. W. Barry, Dermatological Formulations Percutaneous Absorption (Marcel Dekker, 1983).
13. J. N McDougal, G W. Jepson, H. J Clewell, III, M. G MacNaughton, and M. E. Andersen, "A Physiological Pharmacokinetic Model for Dermal Absorption of Vapors in the Rat," Toxicology and Applied Pharmacology 85, 286-294 (1986).
14. R. L. Chinery and K. A. Gleason, "A Compartmental Model for the Prediction of Breath Concentration and Absorbed Dose of Chloroform After Exposure While Showering," Risk Analysis 13(1), 51-62 (1993).
15. C. F H Vickers, "Existance of a Reservoir in the Stratum Corneum," Archives of Dermatology, Supplementary 88, 20-23 (1963).
16. K. B. Bischoff and R. L Dedrick, "Thiopental Pharmacokinetics," Journal of Pharmaceutical Sciences 57(8), 1346-1351 (1968).
17. L. E. Gerlowski and R. K. Jain, "Physiologically-Based Pharmacokinetic Modeling: Principles and Applications," Journal of Pharmaceutical Sciences 72(10), 1103-1127 (1983).
18. M. E. Andersen, H. J. Clewell, III, M. L. Gargas, F. A. Smith, and R. H. Reitz, "Physiologically Based Pharmacokinetics and the Risk Assessment Process for Methylene Chloride," Toxicology and Applied Pharmacology 87, 185-205 (1987).
19. J. C. Ramsey and M. E. Andersen, "A Physiologically Based Description of Inhalation Pharmacokinetics of Styrene in Rats and Humans." Toxicology and Applied Pharmacology 73, 159-175 (1984).
20. R. O. Potts and R. H. Guy, "Predicting Skin Permeability," Pharmacological Research 9(5), 663-669 (1992).
21. P. G. Georgopoulos, A. Roy, and M. A. Gallo, "Reconstruction of short-term Multi-Route Exposure to Volatile Organic Compounds Using Physiologically Based Pharmacokinetic Model," Journal of Exposure Assessment and Environmental Epidemiology 4(3), 309-328 (1994).
22. C. W. Gear, Numerical Initial Value Problems in Ordinary Differential Equations (Prentice-Hall, Englewood Cliffs, NJ, 1971).
23. Dow Chemical Company, Midland, MI, SimuSolv Reference Guide - Volumes I and II.
24. J. Crank, The Mathematics of Diffusion (Oxford University Press, London, 1975).
25. ATSDR, "Toxicological Profile for Chloroform," Agency for Toxic Substances and Disease Registry, U.S. Department of Health & Human Services, Atlanta, GA, Draft: For Public Comment (February 1991).
26. R. A. Corley, A. L. Mendrala, F. A. Smith, D. A. Staats, M. L. Gargas, R. B. Conolly, M. E. Andersen, and R. H. Reitz, "Development of a Physiologically Based Pharmacokinetic Model for Chloroform," Toxicology and Applied Pharmacology 103, 512-527 (1990).
27. C. P. Weisel and T. A Shepard, "Chloroform Exposure and the Resulting Body Burden Associated with Swimming in Chlorinated Pools," in R. Wang (ed.), Drinking Water Contamination and Health (Marcel Dekker, New York, 1993).
28. J. H. Raymer, K. W. Thomas, and S. D. Cooper, "A Device for Sampling of Human Alveolar Breath for the Measurement of Expired Volatile Organic Compounds," Journal of Analytical Toxicology 14(6), 337-344 (1990).
29. W J. Albery and J. Hadgraft, "Percutaneous Absorption Theoretical Description," Journal of Pharmaceutics and Pharmacology 31:129-139 (1979).
30. Report of the Task Group on Reference Man, International Commission on Radiological Protection, ICRP Publication 23 (1975).